Chromatin immunoprecipitation (ChIP)-sequencing studies demonstrate that AR-binding events are similar to those of ERα in ER-positive breast cancer cell lines, indicating that AR may be able to substitute for ER in this context [14]. Here, ESR1 is linked to breast cancer.